NCT04391036View on ClinicalTrials.gov

Randomized Cross-Over Study of Self-Insertion of Two Placebo Vaginal Film Formulations

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

October 26, 2020

Study Completion Date

October 26, 2020

Conditions
SafetyAcceptability
Interventions
DEVICE

High Eudragit® Content Vaginal Film

High (12.8%) Eudragit® Content Vaginal Film

DEVICE

Low Eudragit® Content Vaginal Film

Low (6.4%) Eudragit® Content Vaginal Film

Trial Locations (1)

15213

University of Pittsburgh, Magee Womens Hospital, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Katherine Bunge

OTHER

NCT04391036 - Randomized Cross-Over Study of Self-Insertion of Two Placebo Vaginal Film Formulations | Biotech Hunter | Biotech Hunter